Luke Engelking, MD, PhD
Dr. Engelking is originally from Houston, Texas and first came to UT Southwestern for joint MD/PhD training (2000-2007), where he studied cholesterol and fat metabolism under the tutelage of Nobel Laureates Goldstein and Brown. He then completed his clinical training in internal medicine at Massachusetts General Hospital (2007-2010), an affiliate of Harvard Medical School. Drawn by the opportunity to study lipid metabolism in the intestine, he returned to UT Southwestern for a fellowship in gastroenterology and hepatology (2010-2014) and thereafter joined the faculty of the Departments of Molecular Genetics and Internal Medicine (Division of Digestive and Liver Diseases) and the Center for Human Nutrition. His current research interests include understanding the roles that lipids, particularly cholesterol, play in the growth of intestinal cells both in normal health and in states of uncontrolled growth, such as intestinal cancers like colorectal cancer. He practices general gastroenterology and serves as a teaching attending of fellows, residents, and students at Parkland Memorial Hospital.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:12/13/2021Date updated:04/06/2024
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.